Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganitumab in recurrent platinum-sensitive ovarian cancer
NCT00719212Phase 2Completed
- Sponsor
- Translational Research In Oncology
- Start
- Jan 2009
- Primary completion
- May 2013
- Modality
- Monoclonal Antibodies
- Countries
- 7
01
Overview
A Phase 2 trial of ganitumab in ovarian epithelial carcinoma, sponsored by Translational Research In Oncology. Started Jan 2009; status: completed.
02
Drugs
ganitumab
03
Conditions
ovarian epithelial carcinoma
Beyond the preview
Go deeper on NCT00719212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00719212.